Correlation Between GlaxoSmithKline PLC and Myriad Genetics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Myriad Genetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Myriad Genetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Myriad Genetics, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Myriad Genetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Myriad Genetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Myriad Genetics.

Diversification Opportunities for GlaxoSmithKline PLC and Myriad Genetics

0.46
  Correlation Coefficient

Very weak diversification

The 3 months correlation between GlaxoSmithKline and Myriad is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Myriad Genetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Myriad Genetics and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Myriad Genetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Myriad Genetics has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Myriad Genetics go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Myriad Genetics

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to generate 0.54 times more return on investment than Myriad Genetics. However, GlaxoSmithKline PLC ADR is 1.84 times less risky than Myriad Genetics. It trades about 0.13 of its potential returns per unit of risk. Myriad Genetics is currently generating about -0.1 per unit of risk. If you would invest  3,395  in GlaxoSmithKline PLC ADR on November 3, 2024 and sell it today you would earn a total of  132.00  from holding GlaxoSmithKline PLC ADR or generate 3.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Myriad Genetics

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, GlaxoSmithKline PLC is not utilizing all of its potentials. The newest stock price mess, may contribute to short-term losses for the institutional investors.
Myriad Genetics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Myriad Genetics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

GlaxoSmithKline PLC and Myriad Genetics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Myriad Genetics

The main advantage of trading using opposite GlaxoSmithKline PLC and Myriad Genetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Myriad Genetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Myriad Genetics will offset losses from the drop in Myriad Genetics' long position.
The idea behind GlaxoSmithKline PLC ADR and Myriad Genetics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Commodity Directory
Find actively traded commodities issued by global exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets